Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TILRAY BRANDS, INC.

(TLRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Tilray Launches Fast-Acting Medical Cannabis Oral Strips

12/02/2021 | 12:56pm EST


© MT Newswires 2021
All news about TILRAY BRANDS, INC.
01/20TILRAY BRANDS : Boost your 2022 wellness routine with manitoba harvest
PU
01/14SOCIAL BUZZ : Wallstreetbets Stocks Mixed Ahead of Friday's Opening Bell
MT
01/13SOCIAL BUZZ : Wallstreetbets Stocks Slide into Negative Territory; Virgin Galactic Slumps ..
MT
01/13SOCIAL BUZZ : Wallstreetbets Stocks Mixed on Premarket Thursday
MT
01/12SOCIAL BUZZ : Wallstreetbets Stocks Mixed; Led by GameStop, Tesla, Alibaba
MT
01/11SOCIAL BUZZ : Wallstreetbets Stocks Mostly Higher; Robinhood, ContextLogic Biggest Movers
MT
01/11TSX falls ahead of Powell's testimony, pot stocks weigh
RE
01/11Canaccord Lowers Tilray's Price Target to $9 From $12, Maintains Hold Rating
MT
01/11Stifel Nicolaus Lowers Price Target for Tilray to $6.50 From $10, Maintains Hold Rating
MT
01/11Alliance Global Adjusts Tilray's Price Target to $8 From $7, Maintains Neutral Rating
MT
More news
Analyst Recommendations on TILRAY BRANDS, INC.
More recommendations
Financials (USD)
Sales 2022 659 M - -
Net income 2022 -175 M - -
Net Debt 2022 - - -
P/E ratio 2022 -19,5x
Yield 2022 -
Capitalization 2 701 M 2 701 M -
Capi. / Sales 2022 4,10x
Capi. / Sales 2023 3,67x
Nbr of Employees 1 800
Free-Float 96,5%
Chart TILRAY BRANDS, INC.
Duration : Period :
Tilray Brands, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY BRANDS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 5,79 $
Average target price 10,05 $
Spread / Average Target 73,6%
EPS Revisions
Managers and Directors
Irwin David Simon Chairman & Chief Executive Officer
Carl A. Merton Chief Financial Officer
Joshua Eades Chief Science Officer
Catherine Jacobson Vice President-Regulatory & Medical Affairs
Lloyd Brathwaite Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
TILRAY BRANDS, INC.-17.64%2 701
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356